Home > PB Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of TORRENT PHARMACEUTICALS is 13.85.

Share Price ₹2,536.9Apr 19,2024
Market Cap ₹85,847.0 Cr
Book Value₹6,198.1 CrMar2023 - Consolidated Results
Price/Book 13.85xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of TORRENT PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹85,847.0 Cr] as on Apr 19,2024

(/) Book Value [ ₹6,198.1 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 13.85x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '13.85 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of TORRENT PHARMACEUTICALS


PB Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/b ratio is 13.85x.

- TORRENT PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 7.53x.

- TORRENT PHARMACEUTICALS 's operated at median p/b ratio of 7.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/b ratio peaked in Mar2023 at 8.4x.

- TORRENT PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 6.92x.


How does TORRENT PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
TORRENT PHARMACEUTICALS 6,198.0713.8585,847.0
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.52365,311.0
CIPLA LTD23,346.004.65108,623.0
DR REDDYS LABORATORIES LTD23,140.404.2899,134.3
ZYDUS LIFESCIENCES LTD17,515.805.3092,794.9
DIVIS LABORATORIES LTD12,767.107.6397,408.4
MANKIND PHARMA LTD7,435.1612.5893,565.4
LUPIN LTD12,315.605.7270,506.8
AUROBINDO PHARMA LTD26,839.802.3763,697.4
ABBOTT INDIA LTD3,146.0217.6555,528.4
ALKEM LABORATORIES LTD9,044.696.0955,102.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs TORRENT PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.37x
Max industry PB 17.65x
Median industry PB 6.09x
Average industry PB 7.88x



You may also like the below Video Courses